Dissertation > Excellent graduate degree dissertation topics show

Study of Expression of Enhancer of Zeste Homolog 2 and Its Value in Prostate Cancer

Author: WangZhenFan
Tutor: YanChunYin；DingXiang
School: Suzhou University
Course: Surgery
Keywords: EZH2 prostate cancer cells androgen-independent prostate cancer clinical stage radiation therapy
CLC: R737.25
Type: Master's thesis
Year: 2011
Downloads: 27
Quote: 2
Read: Download Dissertation

Abstract


Objective:To detect the expression levels of EZH2 in prostate cancer cell lines （PC-3 and LNCAP） and in the clinical specimens of prostatic hyperplasia,then analyze the relationship between EZH2 and clinical pathological features of the prostate cancer. To detect the expression levels of EZH2 in the PC3 cell before and after radiotherapy. And then discuss the function and mechanism of EZH2 gene in prostate cancer, in order to look for a new bio-marker of diagnosis and theraputic target of prostate cancer.Methods:1. The expression level of EZH2 protein were detected by Western-Blot in prostate cancer PC-3 cell line, LNCAP cell line and normal prostate epithelial RWPE cell line; 2. Clinical specimens of prostate cancer（n=35） and benign prostatic hyperplasia（n=8） were selected, the expression levels of EZH2 mRNA and protein of these specimens were detected by Reverse Transcription PCR and Western-Blot. And then analyze the relationship between the expression levels of EZH2 and the pathological features of prostate cancer; 3. The expression levels of EZH2 in PC-3 cell line were detected by Western-Blot before and after radiotherapy.Results1. The expression levels of EZH2 protein in PC-3 cell line and LNCAP cell line were higher than the RWPE cell line[4.485（3.181,4.774）, 1.235（1.138,1.302） vs 0.588（0.394,0.649）], the expression levels of EZH2 protein had a statistically significant difference in different prostate cell lines （P<0.01）.2. The expression levels of EZH2 mRNA in prostate cancer were higher than benign prostatic hyperplasia, and there was a statistically significant difference between the two groups（1.69±0.19 vs 0.79±0.10,P﹤0.01）; the expression levels of EZH2 protein in prostate cancer were higher than benign prostatic hyperplasia, and the difference was significant between the two groups （1.67±0.20 vs 0.62±0.10,P﹤0.05）.3. The expression levels of EZH2 protein in stage T3-T4 were higher than in stage T1-T2（T3-T4:2.514±0.2809 vs T1-T2:0.9322±0.07062）, there was a statistically significant difference between the two groups（P<0.01）; the expression levels of EZH2 protein in prostate cancer with lymph node metastasis were higher than that in prostate cancer without lymph node metastasis （N1:3.293±0.3566 vs N0:1.177±0.09800）, there was a statistically significant difference between the two groups （P<0.01）; the expression levels of EZH2 protein in prostate cancer with distant metastasis were higher than that in prostate cancer without distant metastasis（M1:3.808±0.4843 vs M0:1.342±0.1261）, and there was a statistically significant difference between the two groups（P<0.01）; the expression levels of EZH2 protein in Androgen-Independent prostate cancer were higher than that in Androgen-Dependent prostate cancer（AIPC:2.535±0.5326 vs ADPC:1.357±0.1386）, there was a statistically significant difference between the two groups（P﹤0.05）. The expression of EZH2 protein was no statistically significant in the age, PSA and Gleason score（P>0.05）.4. The expression levels of EZH2 protein in PC-3 cell line were low after radiotherapy, the expression levels of EZH2 protein in PC-3 cell line were high before radiotherapy, there was a statistically significant difference between the irradiation group and the control group[0.8681（0.667,1.012） vs 3.181（2.793,4.485）,P﹤0.05], there is no statistically significant difference in different hour points of PC-3 cells after radiotherapy.Conclusions1. The expression levels of EZH2 protein in both PC-3 cell line and LNCAP cell line are higher than RWPE cell line, which suggests that EZH2 may play an important role in prostate cancer.2. The expression levels of EZH2 mRNA and protein are higher in prostate cancer specimens than in benign prostatic hyperplasia. In additoion, there is a positive correlation between the expression levels of EZH2 and the clinical stage of prostate cancer. Thus, EZH2 may become a new marker for the diagnosis of prostate cancer.3. The expression levels of EZH2 are higher in AIPC than in ADPC, which suggests that EZH2 may take part in the transformation from ADPC to AIPC.4. The expression levels of EZH2 protein in PC-3 cell line after performing ionizing radiation are lower than before, which suggests that ionizing radiation can significantly reduce the expression of EZH2 in the PC-3 cell line.

Related Dissertations

  1. Image-Guided Adaptive Radiation Therapy of Intensity-Modulated Radiation for Cervical Cancer,R737.33
  2. The Clinical Research for the Effect of Iodine-125 Seeds Implanted in Advanced Bronchial Lung Cancer,R734.2
  3. Effect of β-elemene Combined with Radiotherapy on the Angiogenesis of Lung Adenocarcinoma Xenograft Tumor in Nude Mice,R734.2
  4. Relationship Between Nasal Inverted Papilloma and Human Papillomavirus Subtypes,R739.62
  5. The Expression of DCP4 and FHIT in Gastric Carcinoma and Its Clinic Value,R735.2
  6. The Relationed Analysis between Coagulation Index in Peripheral Blood and Clinical Stage、metastasis in Pre-operative Patients with Gastric Carcinoma,R735.2
  7. Significance of Measurement of CD4~+CD25~+Foxp3~+ Regulatory T Cell in Patients with Lung Cancer,R734.2
  8. The Relative Study of Expression of IL-2、IL-4 in the Tissue of GM,R655.8
  9. The Study on the Staging System of Esophageal Carcinoma in Non-surgical Treatment Setting,R735.1
  10. The Expression of microRNA-101 and EZH2 in Prostate Cancer Stem Cells,R737.25
  11. EZH2 expression in gastric carcinoma and its clinical significance,R735.2
  12. The Expression of the HRG-1 Gene in Bladder Cell Carcinoma and Normal Bladder Tissue,R737.14
  13. Association Study among MRI, Pathology and Clinical Stages of the Cervical Spondylotic Myelopathy,R681.53
  14. EZH2 and PTEN Protein Expression in Ovarian Tumors and Clinical Significance,R737.31
  15. The Significance and Expression of EZH2, Bmi-1, Survivin and Survivin-3B Gene in Transitional Cell Carcinoma of Bladder,R737.14
  16. Expression of EZH2 and PTEN in Prostate Cancer and its Clinicopathologic Significance,R737.25
  17. Canine Spinal Conformal Intensity Modulated Radiation Therapy after the Dynamic Changes of MBP and Its Significance,R651.2
  18. Expression and Significance of EZH2 and CBX7 in Colorectal Cancer,R735.3
  19. To Investigate the Role of the Chinese Herbal Medicine Xianhuayin on the Reversal of Premalignant Mucosal Lesions in the Golden Hamster Buccal Pouch with Ultramicrostructure and Immunohistochemical Method,R739.8
  20. Analysis of the Related Factors of Survival and Life Quality of Postoperation Esophageal Cancer,R735.1
  21. The Pre-hospital Factors of Clinical Staging of Necrotizing Enterocolitis: Multifactors Analysis from Single Center,R722.1

CLC: > Medicine, health > Oncology > Genitourinary tumors > Male genitalia tumors > Prostate cancer
© 2012 www.DissertationTopic.Net  Mobile